Advertisement

Topics

Biotech firm Grid signs deal with Duke U. to develop cancer antibodies

05:07 EDT 24 Aug 2017 | SmartBrief

Grid Therapeutics was granted exclusive rights by Duke University to intellectual property covering antibodies for complement -More

Original Article: Biotech firm Grid signs deal with Duke U. to develop cancer antibodies

NEXT ARTICLE

More From BioPortfolio on "Biotech firm Grid signs deal with Duke U. to develop cancer antibodies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...